Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
China
Sponsor
Yongquan Shi
Enrollment target
~46 participants
Started
March 2026
Primary completion
March 2027
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yongquan Shi
Yongquan Shi